Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
$148.63
+1.0%
$137.02
$95.11
$189.49
$84.94B1.593.93 million shs1.84 million shs
DaVita Inc. stock logo
DVA
DaVita
$143.43
+0.6%
$140.24
$131.76
$179.60
$10.83B1.11807,899 shs582,817 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$27.16
+0.4%
$28.24
$17.93
$30.46
N/A0.87332,081 shs190,510 shs
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$380.43
+1.2%
$375.75
$289.98
$417.14
$91.52B1.471.45 million shs935,591 shs
Magellan Health, Inc. stock logo
MGLN
Magellan Health
$94.99
$94.79
$91.04
$99.36
$2.50B1.03238,670 shsN/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$183.49
+0.5%
$183.88
$153.99
$243.25
$11.93B1.28782,821 shs493,166 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
+0.96%+4.92%+12.46%+16.38%+23.30%
DaVita Inc. stock logo
DVA
DaVita
+0.70%+0.50%+5.51%-1.84%+1.33%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+0.43%-2.81%-5.05%+8.53%+36.39%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
+1.24%+0.51%+2.61%+13.42%+17.30%
Magellan Health, Inc. stock logo
MGLN
Magellan Health
0.00%0.00%0.00%0.00%0.00%
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
+0.50%+1.23%+7.33%+4.67%-0.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
4.1457 of 5 stars
2.51.02.51.82.22.52.5
DaVita Inc. stock logo
DVA
DaVita
4.46 of 5 stars
2.02.00.04.52.91.73.8
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
3.3958 of 5 stars
1.04.02.50.01.90.05.0
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
4.897 of 5 stars
2.45.02.54.52.72.52.5
Magellan Health, Inc. stock logo
MGLN
Magellan Health
N/AN/AN/AN/AN/AN/AN/AN/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
4.9692 of 5 stars
2.25.01.74.62.83.33.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
2.95
Moderate Buy$161.008.32% Upside
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$164.5014.69% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
2.00
Hold$27.802.37% Upside
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2.74
Moderate Buy$395.714.02% Upside
Magellan Health, Inc. stock logo
MGLN
Magellan Health
0.00
N/AN/AN/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
2.40
Hold$224.7722.50% Upside

Current Analyst Ratings Breakdown

Latest HCA, FMS, UHS, MGLN, APO, and DVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/11/2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$160.00 ➝ $173.00
7/10/2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$160.00 ➝ $170.00
7/10/2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$156.00 ➝ $168.00
7/10/2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$150.00 ➝ $155.00
6/23/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$376.00 ➝ $404.00
6/9/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$355.00 ➝ $410.00
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$366.00 ➝ $416.00
6/2/2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/29/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$320.00 ➝ $385.00
5/23/2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$158.00 ➝ $160.00
(Data available from 7/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
$24.62B3.45$6.59 per share22.54$52.26 per share2.84
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.84$19.25 per share7.45$4.83 per share29.69
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$20.63BN/A$4.89 per share5.55$29.08 per shareN/A
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$71.59B1.28$36.33 per share10.47$2.19 per share173.71
Magellan Health, Inc. stock logo
MGLN
Magellan Health
$4.58B0.55$5.57 per share17.06$73.03 per share1.30
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$15.83B0.75$26.79 per share6.85$104.94 per share1.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
$4.58B$5.7126.0315.731.6114.59%13.45%1.06%8/5/2025 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.0914.2111.280.986.63%176.11%4.66%8/5/2025 (Estimated)
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$582.08M$1.1224.2514.140.643.18%6.25%2.88%7/29/2025 (Estimated)
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.76B$22.4916.9213.571.308.07%1,063.91%10.10%7/25/2025 (Estimated)
Magellan Health, Inc. stock logo
MGLN
Magellan Health
$382.33M$11.478.2827.86N/A6.26%1.81%1.05%N/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$1.14B$17.8210.3010.370.747.44%17.79%8.27%7/23/2025 (Estimated)

Latest HCA, FMS, UHS, MGLN, APO, and DVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
$1.89N/AN/AN/A$1.01 billionN/A
8/5/2025Q2 2025
DaVita Inc. stock logo
DVA
DaVita
$2.70N/AN/AN/A$3.36 billionN/A
7/29/2025Q2 2025
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.47N/AN/AN/AN/AN/A
7/23/2025Q2 2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$4.87N/AN/AN/A$4.24 billionN/A
7/22/2025Q2 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$6.20N/AN/AN/A$18.49 billionN/A
5/12/2025Q1 2025
DaVita Inc. stock logo
DVA
DaVita
$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion
5/6/2025Q1 2025
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.43$0.44+$0.01$0.26$4.71 billion$5.54 billion
5/2/2025Q1 2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
$1.84$1.82-$0.02$0.68$977.14 million$5.55 billion
4/28/2025Q1 2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$4.36$4.84+$0.48$4.80$4.16 billion$4.10 billion
4/25/2025Q1 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.75$6.45+$0.70$6.45$18.26 billion$18.32 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
$2.041.37%N/A35.73%3 Years
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.572.10%N/A50.89%N/A
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$2.880.76%N/A12.81%6 Years
Magellan Health, Inc. stock logo
MGLN
Magellan Health
N/AN/AN/AN/AN/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$0.800.44%N/A4.49%N/A

Latest HCA, FMS, UHS, MGLN, APO, and DVA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
quarterly$0.720.84%6/16/20256/16/20256/30/2025
5/14/2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
quarterly$0.200.43%6/2/20256/2/20256/16/2025
5/9/2025
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
annual$0.78711.9%5/23/20255/23/20256/6/2025
5/2/2025
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
quarterly$0.511.48%5/16/20255/16/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
0.34
1.36
1.36
DaVita Inc. stock logo
DVA
DaVita
23.18
1.25
1.20
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.40
1.46
1.08
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
69.07
1.19
1.06
Magellan Health, Inc. stock logo
MGLN
Magellan Health
0.27
2.92
2.86
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
0.67
1.32
1.23
CompanyEmployeesShares OutstandingFree FloatOptionable
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
5,108571.49 million522.92 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
76,00075.50 million73.99 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,384N/AN/AOptionable
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
316,000240.57 million237.45 millionOptionable
Magellan Health, Inc. stock logo
MGLN
Magellan Health
9,00026.33 million22.62 millionOptionable
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
99,00065.00 million54.34 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Apollo Global Management stock logo

Apollo Global Management NYSE:APO

$148.63 +1.45 (+0.99%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$148.75 +0.12 (+0.08%)
As of 08:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions. For credit strategies, the firm focuses to invest in multi-sector credit, semi-liquid credit, direct lending, first lien, unitranche, whole loans and private credit. The firm provides its services to endowment and sovereign wealth funds, as well as other institutional and individual investors. It manages client focused portfolios. The firm launches and manages hedge funds for its clients. It also manages real estate funds and private equity funds for its clients. The firm invests in the fixed income and alternative investment markets across the globe. Its fixed income investments include income-oriented senior loans, bonds, collateralized loan obligations, structured credit, opportunistic credit, non-performing loans, distressed debt, mezzanine debt, and value oriented fixed income securities. The firm seeks to invest in chemicals, commodities, consumer and retail, oil and gas, metals, mining, agriculture, commodities, distribution and transportation, financial and business services, manufacturing and industrial, media distribution, cable, entertainment and leisure, telecom, technology, natural resources, energy, packaging and materials, and satellite and wireless industries. It also focuses on clean energy, sustainable industry, climate solutions, energy transition, industrial decarbonization, sustainable mobility, sustainable resource use, and sustainable real estate. It seeks to invest in companies based in across Africa, Asia, North America with a focus on United States, Western Europe and Europe. It employs a combination of contrarian, value, and distressed strategies to make its investments. The firm seeks to make investments in the range of $75 million and $1500 million. The firm seeks to invest in companies with Enterprise value between $750 million to $2500 million. The firm conducts in-house research to create its investment portfolio. It seeks to acquire minority and majority positions in its portfolio companies. Apollo Global Management, Inc. was founded in 1990 and is headquartered in New York, New York with additional offices in North America, Asia, Africa and Europe.

DaVita stock logo

DaVita NYSE:DVA

$143.43 +0.88 (+0.61%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$143.38 -0.04 (-0.03%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$27.16 +0.12 (+0.43%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$27.17 +0.01 (+0.05%)
As of 08:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

HCA Healthcare stock logo

HCA Healthcare NYSE:HCA

$380.43 +4.36 (+1.16%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$373.50 -6.93 (-1.82%)
As of 08:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Magellan Health stock logo

Magellan Health NASDAQ:MGLN

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

Universal Health Services stock logo

Universal Health Services NYSE:UHS

$183.49 +0.97 (+0.53%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$185.41 +1.92 (+1.05%)
As of 08:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.